4/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: March 7, 2014
Period of Report: March 3, 2014
Accession Number: 0001012975-14-000141

View Document ↗ View on SEC.gov ↗